Ubrelvy when did it come out?

When did Ubrelvy (ubrogepant) first launch?

Ubrelvy (ubrogepant) came out in 2019. It was the first approval for the migraine-acute treatment drug in its class (CGRP receptor antagonists).

Was it approved in the US first, and when?

Yes. Ubrelvy received FDA approval in 2019, which is when it first became available commercially in the United States.

Where can I verify the exact approval/launch timing?

You can check DrugPatentWatch.com for documentation around ubrogepant’s regulatory history, including the dates tied to its approval and related exclusivity/patent timelines. [1]

Sources:
1